← Back to Search

Technology-Based Behavioral Intervention for Reducing Sugary Drink Intake

N/A
Waitlist Available
Led By Jamie M Zoellner, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English speaking adults, 18 years of age or older, who consume more than 200 kcals of SSB/day
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months
Awards & highlights

Study Summary

This trial will test whether a website designed to help people cut down on sugary drinks is more effective than a static Patient Education website.

Who is the study for?
This trial is for English-speaking adults over 18 living in rural Appalachia who drink more than 200 calories of sugary beverages daily and can use an internet-enabled device weekly. Only one person per household may join, and those who consume less or are unwilling to use the technology are excluded.Check my eligibility
What is being tested?
The iSIPsmarter study tests a behavioral intervention aimed at reducing sugary drink intake against a standard patient education website. Participants will be randomly assigned to either the interactive iSIPsmarter program or static information, with follow-ups at 3, 6, and 18 months.See study design
What are the potential side effects?
Since this trial involves educational content rather than medication, traditional side effects aren't expected. However, participants might experience changes in diet habits or psychological discomfort if struggling with behavior change.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18, speak English, and drink more than 200 calories of sugary drinks daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline sugar-sweetened beverage at 9-weeks
Secondary outcome measures
Change from baseline overall dietary quality at 9-weeks, 6-months and 18 months
Change from baseline overall quality of life at 9-weeks, 6-months and 18 months
Change from baseline sugar-sweetened beverage at 6-months and 18 months
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iSIPsmarterExperimental Treatment1 Intervention
iSIPsmarter is a technology-based behavioral and health literacy intervention. It is comprised of six Internet-delivered Cores, an integrated short message service (SMS) strategy to engage users in tracking SSB behaviors, and the incorporation of a cellular enabled scale for in-home weight tracking. Participants will be prompted (via email or text) to self-monitor their sugar-sweetened beverage intake. iSIPsmarter is a highly interactive, structured, and self-guided program that uses strategies previously proven to promote behavior change. iSIPsmarter also incorporates a stepped care approach to re-engage users who struggle to complete components.
Group II: Patient Education (PE)Active Control1 Intervention
he PE website will include scientifically accurate information that is typical of nutrition education websites and will include information about SSB recommendations, types of SSB and portion size, SSB-related health risks, energy balance information, identifying personal motivators and barriers to reducing SSB intake, interpreting SSB nutrition labels, and recognizing media influences and misclaims in SSB advertisements, as well as printable forms to track SSB and weight. Unlike iSIPsmarter, the content will not be tailored and will be presented all at once.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
760 Previous Clinical Trials
1,250,181 Total Patients Enrolled
University of North CarolinaOTHER
168 Previous Clinical Trials
1,450,077 Total Patients Enrolled
Jamie M Zoellner, PhDPrincipal InvestigatorUniversity of Virginia
2 Previous Clinical Trials
115 Total Patients Enrolled
~64 spots leftby Jun 2025